Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline in Preschoolers with Cystic Fibrosis
NCT02950883Phase 3Completed
- Sponsor
- University of Washington
- Start
- Mar 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 9
01
Overview
Phase 3, randomised, double-blind trial of hypertonic saline in cystic fibrosis (CF) (2 arms), sponsored by University of Washington. Primary endpoint: Chest CT at 48 weeks. Started Mar 2015; status: completed.
02
Drugs
hypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02950883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02950883.